SCHEMBL7673595

SCHEMBL7673595

CCCCn1cnc2c(OC)nc(Nc3ccc(OCC)cc3)nc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
NFKB1 P19838 1/20 0.45
CDK2 P24941 7/20 0.44
PDGFRA P16234 6/20 0.44
CCNE1 P24864 6/20 0.44
PDE4B Q07343 1/20 0.44
PDE4D Q08499 1/20 0.44
CTSL P07711 1/20 0.44
CDK1 P06493 1/20 0.44
MAPT P10636 7/20 0.44
CCNA2 P20248 1/20 0.41
CCNA1 P78396 1/20 0.41
HPGD P15428 1/20 0.41
SYK P43405 1/20 0.41
HTT P42858 2/20 0.40
MEN1 O00255 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7674300 0.94 CTSL (0.50) CDK2PDGFRACCNE1PDE4BPDE4D
SCHEMBL7358873 0.88 CTSL (0.46) CDK2PDGFRACCNE1CTSLCDK1
SCHEMBL7661515 0.88 CCNE1 (0.54) CDK2PDGFRACCNE1CTSLCDK1
SCHEMBL7670599 0.87 CTSL (0.42) KDM4ENFKB1CDK2PDGFRACCNE1
SCHEMBL7674135 0.87 PDGFRA (0.43) CDK2PDGFRACCNE1PDE4BPDE4D
SCHEMBL7666144 0.84 CDK4 (0.45) KDM4ECDK2PDGFRACCNE1CTSL
SCHEMBL7674302 0.84 PDGFRA (0.44) CDK2PDGFRACCNE1CTSLCDK1
SCHEMBL7672863 0.84 PDGFRA (0.52) CDK2PDGFRACCNE1
SCHEMBL7667683 0.84 CCNE1 (0.55) KDM4ENFKB1CDK2PDGFRACCNE1
SCHEMBL7668634 0.84 CCNE1 (0.54) CDK2PDGFRACCNE1CTSLCDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US disclosed